Monograph Capital Holdings Advisors, LLC

13D and 13G Filings

13D/G filings
13D on 1 security
CIK
0001988760
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 1 security · may seek to influence control
UroGen Pharma Ltd. 13D/A
URGN · M96088105
1.9% 6/9/2025
Event 6/5/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.